Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.

BE Claessen; MA Beijk; V Legrand; W Ruzyllo; A Manari; O Varenne; MJ Suttorp; Kedir Adal; K Miquel-Hebert; S Veldhof; JPS Henriques; PWJC (Patrick) Serruys; JJ Piek

doi:10.1161/CIRCINTERVENTIONS.108.831800

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.

BE Claessen
, MA Beijk
, V Legrand
, W Ruzyllo
, A Manari
, O Varenne
, MJ Suttorp
, Kedir Adal
, K Miquel-Hebert
, S Veldhof
, JPS Henriques
, PWJC (Patrick) Serruys
, JJ Piek

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

119 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	339-347
Number of pages	9
Journal	Circulation-cardiovascular interventions
Volume	2
Issue number	4
DOIs	https://doi.org/10.1161/CIRCINTERVENTIONS.108.831800
Publication status	Published - 2009

Research programs

EMC COEUR-09

Access to Document

10.1161/CIRCINTERVENTIONS.108.831800

http://hdl.handle.net/1765/65858

Cite this

Claessen, BE., Beijk, MA., Legrand, V., Ruzyllo, W., Manari, A., Varenne, O., Suttorp, MJ., Adal, K., Miquel-Hebert, K., Veldhof, S., Henriques, JPS., Serruys, PWJC., & Piek, JJ. (2009). Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circulation-cardiovascular interventions, 2(4), 339-347. https://doi.org/10.1161/CIRCINTERVENTIONS.108.831800

@article{cf1ff722af134d1e8f41eee4a948faee,

title = "Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.",

author = "BE Claessen and MA Beijk and V Legrand and W Ruzyllo and A Manari and O Varenne and MJ Suttorp and Kedir Adal and K Miquel-Hebert and S Veldhof and JPS Henriques and Serruys, \{PWJC (Patrick)\} and JJ Piek",

year = "2009",

doi = "10.1161/CIRCINTERVENTIONS.108.831800",

language = "Undefined/Unknown",

volume = "2",

pages = "339--347",

journal = "Circulation-cardiovascular interventions",

issn = "1941-7640",

publisher = "Lippincott Williams \& Wilkins",

number = "4",

}

Claessen, BE, Beijk, MA, Legrand, V, Ruzyllo, W, Manari, A, Varenne, O, Suttorp, MJ, Adal, K, Miquel-Hebert, K, Veldhof, S, Henriques, JPS, Serruys, PWJC & Piek, JJ 2009, 'Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.', Circulation-cardiovascular interventions, vol. 2, no. 4, pp. 339-347. https://doi.org/10.1161/CIRCINTERVENTIONS.108.831800

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. / Claessen, BE; Beijk, MA; Legrand, V et al.
In: Circulation-cardiovascular interventions, Vol. 2, No. 4, 2009, p. 339-347.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.

AU - Claessen, BE

AU - Beijk, MA

AU - Legrand, V

AU - Ruzyllo, W

AU - Manari, A

AU - Varenne, O

AU - Suttorp, MJ

AU - Adal, Kedir

AU - Miquel-Hebert, K

AU - Veldhof, S

AU - Henriques, JPS

AU - Serruys, PWJC (Patrick)

AU - Piek, JJ

PY - 2009

Y1 - 2009

U2 - 10.1161/CIRCINTERVENTIONS.108.831800

DO - 10.1161/CIRCINTERVENTIONS.108.831800

M3 - Article

SN - 1941-7640

VL - 2

SP - 339

EP - 347

JO - Circulation-cardiovascular interventions

JF - Circulation-cardiovascular interventions

IS - 4

ER -

Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O et al. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circulation-cardiovascular interventions. 2009;2(4):339-347. doi: 10.1161/CIRCINTERVENTIONS.108.831800